Disc Medicine (IRON) Interest Coverage Ratio (2020 - 2026)
Disc Medicine's (IRON) quarterly Interest Coverage Ratio came in at 55.44 in Q1 2026, down 128.73% year-on-year from 192.98 in Q1 2025, and up 27.48% on a QoQ basis from 76.45 in Q4 2025.
Disc Medicine (IRON) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Interest Coverage Ratio data on file, last reported at 55.44 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 128.73% year-over-year to 55.44 in Q1 2026; TTM through Mar 2026 was 211.8, a 152.56% decrease from a year earlier, with the FY2025 full-year figure at 1.72, down 41.78% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 55.44, up from 76.45 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for IRON reached as high as 159.75 in Q4 2023 and fell as low as 255.59 in Q3 2022.
- Historically, Interest Coverage Ratio has averaged 52.03 across 5 years, with a median of 46.69 in 2025.
- Across the five-year window, Interest Coverage Ratio soared 197.84% in 2023 and sank 8711.18% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 163.27 in 2022, then surged by 197.84% to 159.75 in 2023, then slumped by 136.05% to 57.58 in 2024, then sank by 32.76% to 76.45 in 2025, then grew by 27.48% to 55.44 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 55.44 in Q1 2026, 76.45 in Q4 2025, and 46.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | -55.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.44 |
| Dec 31, 2025 | -76.45 |
| Sep 30, 2025 | -46.69 |
| Jun 30, 2025 | -39.62 |
| Mar 31, 2025 | -24.24 |
| Dec 31, 2024 | -57.58 |
| Mar 31, 2024 | -0.28 |
| Dec 31, 2023 | 159.75 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -0.21 |
| Mar 31, 2023 | -0.90 |
| Dec 31, 2022 | -163.27 |
| Sep 30, 2022 | -255.59 |
| Jun 30, 2022 | -120.15 |
| Mar 31, 2022 | -99.60 |
| Dec 31, 2021 | 85.77 |
| Sep 30, 2021 | -184.50 |
| Jun 30, 2021 | -163.20 |
| Mar 31, 2021 | -8.92 |
| Dec 31, 2020 | -0.13 |